Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for reducing blood sugar and blood fat

A composition and blood lipid technology, applied in the direction of drug combination, active ingredients of iodine compounds, active ingredients of heterocyclic compounds, etc., can solve the problems of high cost and selling price, few health food targets, etc., and achieve low cost and no incompatibility , The effect of sufficient raw material sources

Inactive Publication Date: 2009-11-18
BEIJING LIQIANQIU SCI & TECH DEV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] There are many types of drugs or health products currently used to lower blood sugar and blood lipids, but there are many drugs with toxic side effects, and there are few health food targets and links are lacking, which need to be improved, and the cost and price are high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for reducing blood sugar and blood fat
  • Pharmaceutical composition for reducing blood sugar and blood fat

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Digupi 5000mg,

[0028] Vitamin B 1 3 mg,

[0029] Vitamin B 2 3 mg,

[0030] Vitamin B 6 2 mg,

[0031] Niacinamide 10mg,

[0032] Zinc lactate (calculated as trace element zinc) 10mg,

[0033] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0034] Chromium picolinate (calculated as trace element chromium) 0.01mg,

[0035] Potassium iodate (calculated as trace element iodine) 0.1mg.

[0036] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

Embodiment 2

[0038] Digupi 6000mg,

[0039] Vitamin B 1 3 mg,

[0040] Vitamin B 2 3 mg,

[0041] Vitamin B 6 2 mg,

[0042] Niacinamide 10mg,

[0043] Zinc lactate (calculated as trace element zinc) 8mg,

[0044] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0045] Chromium yeast (calculated as trace element chromium) 0.02mg,

[0046] Sodium molybdate (calculated as trace element molybdenum) 0.03mg.

[0047] Potassium iodate (calculated as trace element iodine) 0.1mg,

[0048] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

Embodiment 3

[0050] Digupi 7000mg,

[0051] Vitamin B 1 3 mg,

[0052] Vitamin B 2 3 mg,

[0053] Vitamin B 6 2 mg,

[0054] Niacinamide 10mg,

[0055] Zinc lactate (calculated as trace element zinc) 8mg,

[0056] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0057] Chromium yeast (calculated as trace element chromium) 0.02mg,

[0058] Copper (calculated as trace element copper) 0.8mg,

[0059] Molybdenum (calculated as trace element molybdenum) 0.06mg,

[0060] Potassium iodate (calculated as trace element iodine) 0.1mg,

[0061] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for reducing blood sugar and blood fat, comprising cortex lycii radicis, vitamin B complex, and trace elements of zinc, selenium, chromium, copper, molybdenum, iodine and manganese. The composition is mainly suitable for hyperglycemia and hyperlipemia crowds, is curative for reducing blood sugar and blood fat, and can be used for a long time or according to the course of treatment.

Description

Technical field: [0001] The invention relates to the technical field of medicine and health products; especially a pharmaceutical composition for lowering blood sugar and blood fat. Background technique: [0002] The composition comprises Digupi, complex vitamin B and trace elements zinc, selenium, chromium, copper, molybdenum, iodine and manganese. [0003] Digupi has the effects of reducing asthenic heat, clearing lung-fire, and cooling blood, and has strong antipyretic, blood sugar and blood lipid-lowering effects. Traditional Chinese medicine books and modern clinical records have Digupi single or compound prescriptions for treating diabetes recorded. [0004] B vitamins participate in the metabolism of protein, fat and sugar in the body, and make the excitation and inhibition of brain cells in a balanced state. It includes vitamin B 1 , Vitamin B 2 , Niacinamide, Pantothenic Acid, Biotin, Vitamin B 6 , Vitamin B 12 , folic acid, etc., play a physiological role syne...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/815A61P3/06A61P3/10A61K31/191A61K31/194A61K31/197A61K31/4188A61K31/4415A61K31/455A61K31/51A61K31/519A61K31/525A61K31/714A61K33/04A61K33/18A61K33/24A61K33/32A61K33/34
Inventor 陈欣晶
Owner BEIJING LIQIANQIU SCI & TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com